ProCE Banner Activity

Overview of Relapsed/Refractory Myeloma and Therapeutic Strategies for Patients With Heavily Pretreated Disease After Relapse

Slideset Download
Downloadable slides with expert analysis of treatment strategies for heavily pretreated relapsed/refractory multiple myeloma.

Released: June 25, 2020

Expiration: June 24, 2021

Share

Faculty

Shaji K. Kumar

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

GlaxoSmithKline LLC

Sanofi Genzyme Corp

Program Director Disclosure

Program Director

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota